Alcon | United States

Alcon United States is only available in English. Click below to select a different country.

Select other country

Media Release

Alcon Strengthens Research and Development Team With Addition of Dr. Edward J. Holland

PDF Print

July 28, 2022

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that the world-renowned Professor of Ophthalmology, Edward J. Holland, MD, will join Alcon as a member of the Research and Development (R&D) team.

Dr. Holland is a thought leader in ophthalmology, specializing in the field of cornea and the ocular surface. He will serve as an enterprise Senior Scientific Advisor to Alcon while continuing his private practice. In his role with Alcon, Dr. Holland will be integral in providing strategic input on Alcon’s pipeline and portfolio, including ophthalmic pharmaceuticals.

“Alcon continues to significantly invest in R&D, securing a robust pipeline that will drive future growth and address unmet patient needs,” said Ian Bell, President of Global Business and Innovation at Alcon. "We’re pleased to welcome Dr. Holland as part of the Alcon family. His extensive experience will help shape our future R&D portfolio strategy, especially in the dry eye and pharmaceutical space.”

Dr. Holland’s list of prestigious honors and awards includes the Senior Achievement and Life Achievement Honor Award from the American Academy of Ophthalmology, the Binkhorst and Lindstrom Medals from the American Society of Cataract and Refractive Surgery, and the Castroviejo Award from the Cornea Society. He has been listed in “Best Doctors in America” and has garnered national and international prestige for his expertise.

About Alcon

Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 24,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at  www.alcon.com.

Connect with us on Facebook and LinkedIn.

Media Relations

Mel McCoy
+1 817 363 1247
[email protected]